
Harvey Ramer
@harvey_ramer
I love stocks. I found my niche in biotech and some tech.
ID: 1354266697251827713
27-01-2021 03:15:28
2,2K Tweet
442 Followers
208 Following














Ok National Comprehensive Cancer Network (NCCN) The ball is in your court. Any reduction in target lesions in LGSOC improves QOL. And 17% rr in wild type after multiple lines of prior therapy is worthwhile, considering the alternatives. investor.verastem.com/news-releases/…


